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Abstract
Introduction: The novel coronavirus has spread rapidly around the world with particularly high mortality in the elderly. Care
and nursing homes have become the sites of greatest concentration of cases. We intended to review 30-day mortality of COVID-
19 patients with hip fractures. This is relevant given the disease impact in this age group. Methods: Medline and Embase databases
were searched for relevant studies linked to mortality and morbidity in COVID-19 patients who have undergone non-elective hip
surgeries using the keywords “COVID-19”OR “SARS-cov-2”OR “Coronavirus Infections”; AND “Surgery”OR “Hip”OR
“Fracture”OR “Orthopedics.” We included all patients with hip fractures, but excluded pathological fractures and other non-
traumatic hip pathologies. Four-hundred and eighty-one articles were identified for screening, in addition to an unpublished
case-series of 67 patients that have 3 cases turned positive for COVID 19, yielding a total of 50patients for the final review.
Results: The study included 4 articles published until May 9th 2020 and a case-series: 26(52%) patients were females; the median
age was 86years; hypertension(53.6%), diabetes mellitus type II(28.6%), and coronary artery heart disease(25%) were the most
common comorbidities; 34(68%) patients had intertrochanteric hip fracture and 16(32%) patients had femoral neck fractures;
22(59.5%) patients underwent cephalomedullary nail fixation, 12(32.4%) patients had hemiarthroplasty, and for 3(8.1%) patients,
the type of surgery was not documented; 20(40%) patients died(12patients died before the surgery and 8died after surgery at a
median time of 3days), 29(76.3%) patients had an unremarkable course throughout hospitalization and were discharged including
1(2.6%) patient managed non-operatively, and 1(2.6%) patient was admitted to the ICU after the surgery but eventually dis-
charged. Conclusion: COVID-19 infected elderly patients have a higher 30-days mortality rate compared to non-COVID-19
infected cases. Further studies are warranted to look at the morbidity and mortality rates in COVID-19 positive patients with hip
fractures and to investigate how these outcomes can be improved. Level of evidence: Level IV
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Background
The outbreak of coronavirus disease 2019 (COVID-19) caused
by the 2019 novel coronavirus (SARS-CoV-2) began in
Wuhan, Hubei Province, China in December 2019, and has
rapidly spread throughout the world forcing near total shut
down of most countries.1-3 The pandemic has overwhelmed
healthcare systems, especially intensive care units (ICU), in
the world. To minimize the risk of coronavirus spread, and to
conserve manpower and resources, elective orthopaedic proce-
dures were suspended in most countries. Most guidelines rec-
ommended hospital admission only for those patients who
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needed it. They further recommended surgical treatment only
where its results are superior to non-operative treatment.4-7
Existing literature suggests that COVID-19 affects most
severely older patients and those with comorbidities.8 A group
that has attracted little attention are those with hip fractures.9-12
Generally, hip fractures are associated with increased morbid-
ity and a 30-day mortality rate of 7–10%.13 To date, there is a
dearth of studies looking into the morbidity and mortality rates
among COVID-19 patients with hip fractures. We, therefore,
aim from the current review to investigate the 30-day mortality
caused by COVID-19 in this group of patients.
Methods
Search Strategy
The research question and inclusion criteria for individual stud-
ies were established prior to searching databases. Online data-
bases (Embase and Medline) were used to find literature related
to mortality and morbidity in COVID-19 patients who have
undergone urgent hip surgeries. PubMed was also screened but
it added less relevant articles compared to other databases as
MeSH terms were not established by the time of search date.
Key words included were “COVID-19” OR “SARS-cov-2” OR
“Coronavirus Infections”; AND “Surgery” OR “Hip” OR
“Fracture” OR “Orthopedics.” The search was conducted on
May 9th, 2020 and yielded a total of four-hundred and eighty-
one articles from both databases, without any restriction on
language or date of publication (Table 1).
The following inclusion criteria were used: (1) all levels of
evidence irrespective of the study type, (2) male and female
patients with no age limitation, and (3) all COVID-19 patients
with hip fractures. We excluded patients with (1) pathological
fractures, (2) non-hip fractures, and (3) non-traumatic hip
pathologies.
Study Selection
Combined results of all searches produced four-hundred and
eighty-one articles. Titles and abstracts were screened, yielding
a total of 4 studies that satisfied our inclusion and exclusion
criteria. All reviewers performed a full-text review of the 4
eligible studies and case-series (Figure 1).
Data Abstraction
One reviewer abstracted relevant study data from the final pool
of the included studies and recorded them on a spreadsheet.
These included study and publication information (author, year
of publication, study design, level of evidence, and sample
size), patients’ data (age, sex, comorbidities, and pathology),
surgical details (type of fixation), outcomes (acute respiratory
distress syndrome “ARDS,” respiratory failure, intensive care
unit “ICU” admission, and death).
An unpublished case-series of 67 patients during COVID-19
outbreaks attended orthopaedic clinic at the University of Ver-
ona, Italy until May 14th, 2020 revealed 3 patients were
COVID-19 infected with hip fracture who satisfy our inclusion
criteria, and therefore, were added to the total number of
patients included.
Results
A total of 50 patients were included in the final results. The age
of the patients ranges from 50 to 100 years with a median age of
86 years. Female patients were 26 (52%). All the fractures were
due to low energy injury except for 1 patient with traumatic
brain injury who had a high-velocity (traffic) accident. Nearly
56% of patients had 1 or more comorbidities: hypertension
(53.6%), diabetes mellitus type II (28.6%), and coronary artery
heart disease (25%) were the most common comorbidities; the
medical comorbidities were not reported in 22 patients. Thirty-
four (68%) patients had intertrochanteric fracture and 16 (32%)
patients had femoral neck fractures. Twenty-two (59.5%)
patients underwent cephalomedullary nail fixation, 12
Table 1. Search Strategy of Embase and Medline Databases.
Embase May 9th 2020 Total articles
1) “COVID 19” OR “SARS-cov-2” OR “Coronavirus Infections” 10389
2) “Surgery” OR “Hip” OR “Fracture” OR “Orthopedics” 3813393
3) 1 and 2 258
Medline May 9th 2020 11806
1) “COVID 19” OR “SARS-cov-2” OR “Coronavirus Infections” 2849777
2) “Surgery” OR “Hip” OR “Fracture” OR “Orthopedics” 223
3) 1 and 2
Total from Embase and Medline 481
481Articles • Embase and Medline
67 Articles • After titles screened
4 Articles • After abstracts
screened
50 patients
• 4 articles + 
Authors' series
Figure 1. Flow chart illustrating the article screening process.
2 Geriatric Orthopaedic Surgery & Rehabilitation





Positive Patients Age Sex Comorbidities Pathology
Type of
Surgery Outcome




2 79 F Osteoporosis Femoral neck
fracture
HA Unremarkable





4 80 F HTN, DM, CAHD Intertrochanteric
fracture
x ICU admission (ARDS/
RF), Death
5 84 F HTN, Osteoporosis Intertrochanteric
fracture
x Death
6 85 M Brain injury Intertrochanteric
fracture
x Death
2 Lei et al. 2020 7 III 34 2 1 83 M HTN, CAHD, CVD Femoral neck
fracture
HA ICU admission (ARDS/
RF), Death
2 84 F CAHD Femoral neck
fracture
HA Unremarkable
3 Catellani et al.
2020 8
IV 16 13 1 89 F HTN, DM, MR Intertrochanteric
fracture
CMN Unremarkable





3 84 M HTN, CAHD Femoral neck
fracture
HA Unremarkable
4 84 M HTN, Hepatitis C Intertrochanteric
fracture
CMN Unremarkable
5 90 M HTN, CAHD, CHF Intertrochanteric
fracture
CMN Unremarkable





7 74 M HTN, DAS, Obesity Intertrochanteric
fracture
CMN Unremarkable
8 82 M CKD, BPH Intertrochanteric
fracture
CMN Death
9 86 M HTN, HypoT4 Intertrochanteric
fracture
HA Death
10 88 M DM, CAHD, BPH Femoral neck
fracture
HA Death
11 85 M CAHD, BPH Intertrochanteric
fracture
HA Unremarkable
12 82 M HTN, remote CVA Femoral neck
fracture
CMN Unremarkable
13 85 F DAS Femoral neck
fracture
CMN Death





14 80 F DM Intertrochanteric
fracture
x Death
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Positive Patients Age Sex Comorbidities Pathology
Type of
Surgery Outcome
2 93 M NR Intertrochanteric
fracture
CMN Death
3 85 F NR Intertrochanteric
fracture
x Death
4 100 M NR Intertrochanteric
fracture
x Death
5 89 F NR Intertrochanteric
fracture
x Death
6 95 F NR Intertrochanteric
fracture
x Death
7 88 F NR Femoral neck
fracture
x Death
8 85 F NR Intertrochanteric
fracture
CMN Unremarkable
9 90 M NR Intertrochanteric
fracture
NR Unremarkable
10 95 F NR Intertrochanteric
fracture
CMN Unremarkable
11 89 F NR Femoral neck
fracture
NR Unremarkable
12 87 M NR Intertrochanteric
fracture
CMN Unremarkable
13 77 F NR Femoral neck
fracture
HA Unremarkable
14 92 M NR Intertrochanteric
fracture
CMN Unremarkable
15 86 M NR Femoral neck
fracture
NR Unremarkable
16 91 M OSAHS Femoral neck
fracture
HA Unremarkable
17 94 F NR Intertrochanteric
fracture
CMN Unremarkable
18 85 F NR Intertrochanteric
fracture
CMN Unremarkable
19 88 F NR Intertrochanteric
fracture
CMN Unremarkable
20 97 M NR Intertrochanteric
fracture
CMN Unremarkable
21 84 F NR Intertrochanteric
fracture
CMN Unremarkable
22 72 M NR Femoral neck
fracture
HA Unremarkable





IV 67 3 1 100 F Dementia Intertrochanteric
fracture
CM Unremarkable





3 89 F DAS Femoral neck
fracture
HA Unremarkable
HTN: Hypertension; DM: Diabetes Mellitus type II; CAHD: Coronary Artery Heart Disease; MR: Mitral Regurgitation; HypoT4: Hypothyroidism; DAS:
Depression and Anxiety Syndrome; CHF: Congestive Heart Failure; CVA: Cerebrovascular Accident; VD: Vascular Dementia; BPH: Benign Prostatic Hyperplasia;
CKD: Chronic Kidney Disease; OSAHS: Obstructive Sleep Apnoea Hypopnoea Syndrome; AF: Atrial Fibrillation; AS: Aortic Stenosis; CMN: Cephalomedullary
Nail; HA: Hemiarthroplasty; ARDS: Acute Respiratory Distress Syndrome; RF: Respiratory Failure; NR: Not Reported, X: No Surgery, CM: Conservative
Management.
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(32.4%) patients underwent hemiarthroplasty, and for 3 (8.1%)
patients, the type of surgery was not documented. Twelve
(24%) patients died before the surgery and 8 (16%) patients
died after the surgery (total of 20 patients, 40%). The time from
surgery to death ranged from 1 to 16 days, with a median of 3
days. Twenty-nine (76.3%) patients had an unremarkable
course throughout hospitalization and were discharged includ-
ing 1 (2.6%) patient managed non-operatively, and 1 (2.6%)
patient was admitted to the ICU after the surgery but eventually
discharged (Table 2).
Discussion
Many national guidelines have recommended that patients with
hip fractures undergo surgery within 48 hours of admission
long before the appearance of COVID-19.14,15 Various guide-
lines set during COVID-19 pandemic have, also, identified
patients with hip fractures among those requiring urgent surgi-
cal intervention.4-7 Pre-COVID-19 studies have reported a
30-day mortality rate of 7-10% and postoperative pulmonary
complications rate of 4.9%.12,16
In the present review of 50 patients from 4 studies and case
series, the overall death rate is 40% in COVID-19 positive
patients. The death rate was mainly observed among elderly
patients in their seventh and eighth decades of life. This finding
is consistent with the trend of hip fracture in non COVID-19
elderly patients.17 One study reported only 14-days follow-up
which may underestimate the 30-day mortality rate.13
It is clear from this small group that the mortality rate is
much higher than in the non-COVID-19 patients with hip frac-
tures. The virus’s predilection to target the lungs combined
with the severe discomfort resulting from hip fractures leading
to poor respiratory effort seem to be a plausible explanation for
these patients’ poor condition on admission to hospital and high
preoperative mortality rate. The comparatively lower post-
operative mortality rate may reflect the positive pain relieving
effect of surgical treatment of the fractures allowing for early
rehabilitation and postural drainage of the lungs. What is not
clear are the reasons why so many patients are admitted in such
poor condition with such high preoperative mortality rate. It is
noteworthy that Do Not Resuscitate (DNR) status was not
documented, and therefore, these patients were to be denied
ICU treatment, ventilator support, and cardiopulmonary resus-
citation (CPR) when becoming seriously-ill. Not only being
symptomatic with COVID-19, but also asymptomatic positive
testing and, even simply, coming from a high COVID-19 envi-
ronment (like a nursing home) seems to increase the mortality
rate in patients with hip fractures.10,13 One possible explanation
is that these patients may have had a false negative test.
This review has a number of limitations. The sample size is
small. It included level 3 and 4 retrospective studies that are
prone to selection, recall or misclassification bias, subject to
confounding and cannot determine causation, only association.
Moreover, the studies have some missing data and the reported
number of COVID-19 positive patients with hip fractures since
this pandemic has started is low to run any subgroup analysis.
The authors were contacted for the missing data but, unfortu-
nately, because of the retrospective nature of these studies most
of the requested data were not available. In addition, one of the
included studies was published in a non-peer review journal,
however, only 2 COVID-19 positive patients with hip fractures
were included in that study.
In summary, the review revealed that the combination of
COVID-19 positive and hip fracture carries a particularly high
30-days mortality rate compared to the non-COVID-19 patients
with hip fracture. Clearly, greater protective measures from
both COVID-19 exposure and hip fractures need to be insti-
tuted for this vulnerable group of patients. Given the evolving
nature of the COVID-19 pandemic and its vast and rapid spread
among population, especially nursing homes, it is important to
report all data together so that a greater understanding of the
disease in this group of patients is attained. Further studies are
warranted to look at the morbidity and mortality rates in
COVID-19 positive patients with hip fractures and to investi-
gate how these outcomes can be improved.
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